Development, Execution and Acceptance of a Manualized Dance/Movement Therapy Treatment Protocol for the Clinical Trial in the Treatment of Negative Symptoms and Psychosocial Functioning in Schizophrenia

被引:0
|
作者
Karolina Bryl
Sherry Goodill
机构
[1] College of Nursing and Health Professions,Department of Creative Arts Therapies
[2] Drexel University,undefined
来源
American Journal of Dance Therapy | 2020年 / 42卷
关键词
Dance/movement therapy; Manualized treatment protocol; Intervention manual; Schizophrenia; Negative symptoms; Psychosocial functioning;
D O I
暂无
中图分类号
学科分类号
摘要
The use of manual-based interventions that aim to improve outcomes and that allow for replication become a research standard in recent years. Currently, the dance/movement therapy English language literature contains few if any works on specific guidelines or models to help researchers conceptualize, develop, pilot, revise and execute treatment protocols. Therefore, this manuscript describes in detail the development of manualized dance/movement therapy treatment protocol for a clinical trial on the negative symptoms and psychosocial functioning in individuals with schizophrenia. It provides a comprehensive description of the step-by-step process of the creation and implementation of the intervention manual. As such it offers a guideline to help researchers conceptualize, develop, pilot, revise and execute the treatment protocol. Feasibility and acceptance findings are included. Discussion of the importance of the use of manualized treatment protocols in dance/movement therapy research and their limitations follows.
引用
收藏
页码:150 / 175
页数:25
相关论文
共 50 条
  • [31] Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness
    Pawelczyk, Tomasz
    Kolodziej-Kowalska, Emilia
    Pawelczyk, Agnieszka
    Rabe-Jablonska, Jolanta
    NEUROPSYCHOBIOLOGY, 2014, 70 (03) : 158 - 164
  • [32] Early treatment induced improvement of negative symptoms predicts cognitive functioning in treatment naive first episode schizophrenia: A 2-year followup
    Schuepbach, D
    Hill, SK
    Sanders, RD
    Hell, D
    Keshavan, MS
    Sweeney, JA
    SCHIZOPHRENIA BULLETIN, 2004, 30 (04) : 837 - 848
  • [33] The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial
    Lecrubier, Y.
    Quintin, P.
    Bouhassira, M.
    Perrin, E.
    Lancrenon, S.
    ACTA PSYCHIATRICA SCANDINAVICA, 2006, 114 (05) : 319 - 327
  • [34] Efficacy of Second-Generation-Antipsychotics in the treatment of negative symptoms of schizophrenia: A meta-analysis of randomized clinical trials
    Darba, Josep
    Minoves, Agnes
    Rojo, Emilio
    Jimenez, Francesca
    Rejas, Javier
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2011, 4 (03): : 126 - 143
  • [36] A randomized, double blind, sham-controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of negative symptoms in schizophrenia
    Kumar, Nand
    Vishnubhatla, Sreenivas
    Wadhawan, Ashima Nehra
    Minhas, Sujata
    Gupta, Prashant
    BRAIN STIMULATION, 2020, 13 (03) : 840 - 849
  • [37] A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
    Farokhnia, Mehdi
    Sabzabadi, Maryam
    Pourmahmoud, Hossein
    Khodaie-Ardakani, Mohammad-Reza
    Hosseini, Seyed-Mohammad-Reza
    Yekehtaz, Habibeh
    Tabrizi, Mina
    Rezaei, Farzin
    Salehi, Bahman
    Akhondzadeh, Shahin
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 533 - 542
  • [38] Acceptance and Commitment Therapy for Inpatients with Psychosis (the REACH Study): Protocol for Treatment Development and Pilot Testing
    Gaudiano, Brandon A.
    Davis, Carter H.
    Epstein-Lubow, Gary
    E., Jennifer Johnson
    Mueser, Kim T.
    Miller, Ivan W.
    HEALTHCARE, 2017, 5 (02)
  • [39] A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
    Mehdi Farokhnia
    Maryam Sabzabadi
    Hossein Pourmahmoud
    Mohammad-Reza Khodaie-Ardakani
    Seyed-Mohammad-Reza Hosseini
    Habibeh Yekehtaz
    Mina Tabrizi
    Farzin Rezaei
    Bahman Salehi
    Shahin Akhondzadeh
    Psychopharmacology, 2014, 231 : 533 - 542
  • [40] Cilostazol adjunctive therapy in treatment of negative symptoms in chronic schizophrenia: Randomized, double-blind, placebo-controlled study
    Rezaei, Farzin
    Mesgarpour, Bita
    Jeddian, Alireza
    Zeionoddini, Atefeh
    Mohammadinejad, Payam
    Salardini, Elaheh
    Shahriari, Mona
    Zeinoddini, Arefeh
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2017, 32 (04)